Debating the Future of Sickle Cell Disease Curative Therapy: Haploidentical Hematopoietic Stem Cell Transplantation vs. Gene Therapy

Hematopoietic stem cell transplantation (HSCT) is a well-established curative therapy for patients with sickle cell disease (SCD) when using a human leukocyte antigen (HLA)-matched sibling donor. Most patients with SCD do not have a matched sibling donor, thereby significantly limiting the accessibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kassim, Adetola A., Leonard, Alexis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409766/
https://www.ncbi.nlm.nih.gov/pubmed/36013014
http://dx.doi.org/10.3390/jcm11164775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409766/
https://www.ncbi.nlm.nih.gov/pubmed/36013014
http://dx.doi.org/10.3390/jcm11164775

Ejemplares similares